Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 2,905 | 285 | 2,601 |
| Samples | 570 | 98 | 467 |
| Peptides | 428 | 71 | 379 |
Function
ZIC4 · Zic family zinc finger 4
This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. Members of this family are important during development, and have been associated with X-linked visceral heterotaxy and holoprosencephaly type 5. This gene is closely linked to the gene encoding zinc finger protein of the cerebellum 1, a related family member on chromosome 3. Heterozygous deletion of these linked genes is involved in Dandy-Walker malformation, which is a congenital cerebellar malformation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Dec 2009].
Isoforms & Proteins
6 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 362 amino-acid changes on canonical ENST00000383075 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in ZIC4 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in ZIC4 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 5/40 12% | 0/0 0% |
| Chronic Myelogenous Leukemia | 2/25 8% | 0/0 0% |
| Glioblastoma | 5/98 5% | 0/0 0% |
| Non-Small Cell Lung Carcinoma | 16/304 5% | 63/1390 5% |
| Endometrial Carcinoma | 6/42 14% | 19/612 3% |
| Squamous Cell Lung Carcinoma | 1/57 2% | 29/810 4% |
| Gastric Carcinoma | 4/74 5% | 52/1809 3% |
| Neuroendocrine Tumour | 8/154 5% | 9/577 2% |
| Colorectal Carcinoma | 9/143 6% | 68/3239 2% |
| Small Cell Lung Carcinoma | 0/9 0% | 16/752 2% |
| Oral Cavity Carcinoma | 1/54 2% | 0/0 0% |
| Melanoma | 5/210 2% | 31/1899 2% |
| Head and Neck Carcinoma | 3/85 4% | 23/1574 1% |
| Hodgkins Lymphoma | 0/16 0% | 2/122 2% |
| Plasma Cell Myeloma | 2/44 5% | 3/305 1% |
| Cervical Carcinoma | 2/35 6% | 4/422 1% |
| Other Solid Cancers | 0/94 0% | 20/1515 1% |
| Acute Myeloid Leukemia | 1/90 1% | 0/0 0% |
| Bladder Carcinoma | 2/58 3% | 9/956 1% |
| Esophageal Carcinoma | 0/23 0% | 8/769 1% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 24/2550 1% |
| Other Sarcomas | 3/69 4% | 3/699 0% |
| Biliary Tract Carcinoma | 0/54 0% | 7/950 1% |
| Glioma | 2/52 4% | 12/2127 1% |
| Hepatocellular Carcinoma | 0/46 0% | 14/2210 1% |
| Breast Carcinoma | 7/144 5% | 10/3264 0% |
| Ovarian Carcinoma | 1/109 1% | 4/998 0% |
| Non-Cancerous | 0/104 0% | 4/830 0% |
| Prostate Carcinoma | 1/13 8% | 8/2105 0% |
| Pancreatic Carcinoma | 0/89 0% | 7/1611 0% |
Mutation Distribution
Where ZIC4 is mutated · all tissues, split by cell line vs tissue
How many mutations in ZIC4 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 40 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 2,905 mutations in ZIC4
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|